Transvenous Intramyocardial Cellular Delivery Increases Retention in Comparison to Intracoronary Delivery in a Porcine Model of Acute Myocardial Infarction
Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4...
Saved in:
Published in | Journal of interventional cardiology Vol. 21; no. 5; pp. 424 - 431 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Malden, USA
Blackwell Publishing Inc
01.10.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI.
Methods: Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre‐ and post‐cells. Pigs underwent 90‐minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over‐the‐wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess™ catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed.
Results: Procedures were performed without complication and monitoring was uneventful. 1 × 108 MNC were isolated from each bone marrow (BM) preparation and 1 × 107 MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01).
Conclusion: We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary. |
---|---|
AbstractList | Background:
Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI.
Methods:
Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre‐ and post‐cells. Pigs underwent 90‐minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over‐the‐wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess™ catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed.
Results:
Procedures were performed without complication and monitoring was uneventful. 1 × 10
8
MNC were isolated from each bone marrow (BM) preparation and 1 × 10
7
MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone
(
P
= 0.01
).
Conclusion:
We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary. Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre- and post-cells. Pigs underwent 90-minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over-the-wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. Procedures were performed without complication and monitoring was uneventful. 1 x 10(8) MNC were isolated from each bone marrow (BM) preparation and 1 x 10(7) MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary. BACKGROUNDClinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. METHODSDomestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre- and post-cells. Pigs underwent 90-minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over-the-wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. RESULTSProcedures were performed without complication and monitoring was uneventful. 1 x 10(8) MNC were isolated from each bone marrow (BM) preparation and 1 x 10(7) MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). CONCLUSIONWe have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary. Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine whether transvenous intramyocardial (TVIM) approach was advantageous for cellular retention in AMI. Methods: Domestic pigs (n = 4) underwent catheterization with coronary angiography and ventriculography prior to infarction and pre‐ and post‐cells. Pigs underwent 90‐minute balloon occlusion of the left anterior descending artery (LAD). After one week they were prepared for IC (n = 2) or TVIM (n = 2) delivery of bone marrow mononuclear cells (MNC) labeled with GFP. IC infusion used an over‐the‐wire catheter to engage the LAD and balloon inflation to prevent retrograde flow. Venography via the coronary sinus was used for TVIM delivery. The anterior interventricular vein was engaged with a guidewire allowing use of the TransAccess™ catheter that is outfitted with an ultrasound tip for visualization. Animals were sacrificed one hour after delivery and tissue was analyzed. Results: Procedures were performed without complication and monitoring was uneventful. 1 × 108 MNC were isolated from each bone marrow (BM) preparation and 1 × 107 MNC delivered. Ventriculography at one week revealed wall motion abnormalities consistent with an anterior AMI. TVIM and IC delivery revealed mean 452 cells per section and 235 cells per section on average, respectively, in the infarct zone (P = 0.01). Conclusion: We have demonstrated that TVIM approach for cell delivery is feasible and safe. Moreover, this approach may provide an advantage over IC infusion in retention of the cellular product; however, larger studies will be necessary. |
Author | GEORGE, JON C. GOLDBERG, JONATHAN JOSEPH, MATTHEW CRIST, JOSHUA POMPILI, VINCENT J. DAS, HIRANMOY ABDULHAMEED, NASREEN |
Author_xml | – sequence: 1 givenname: JON C. surname: GEORGE fullname: GEORGE, JON C. organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio – sequence: 2 givenname: JONATHAN surname: GOLDBERG fullname: GOLDBERG, JONATHAN organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio – sequence: 3 givenname: MATTHEW surname: JOSEPH fullname: JOSEPH, MATTHEW organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio – sequence: 4 givenname: NASREEN surname: ABDULHAMEED fullname: ABDULHAMEED, NASREEN organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio – sequence: 5 givenname: JOSHUA surname: CRIST fullname: CRIST, JOSHUA organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio – sequence: 6 givenname: HIRANMOY surname: DAS fullname: DAS, HIRANMOY organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio – sequence: 7 givenname: VINCENT J. surname: POMPILI fullname: POMPILI, VINCENT J. organization: Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/19012733$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkc2O0zAUhS00iOkMvALyil2KHceJvQBpKMxQmB80KmJpOc4NuCR2sdPSPgsvi0OrDuzwxrbu-c617zlDJ847QAhTMqVpvVxOKS9IJqhg05wQMSWESTLdPkKTY-EETYiQZVawvDpFZzEuCckJ5_kTdEoloXnF2AT9WgTt4gacX0c8d0PQ_c4bHRqrOzyDrlt3OuC30NkNhF1SmAA6QsT3MIAbrHfYOjzz_UoHG9Nt8Hsb44N3OiFHNuk0_uSDsQ7wjW-gw77FF2Y9pOtD07lrdTCj81P0uNVdhGeH_Rx9vny3mL3Pru-u5rOL68zwqiSZJoUGxuqmkpTltMoFKySXJeNGgyhlbeqipbysQACXNW9IAXnNeCsNM5zW7By93vuu1nUPjYHx_Z1aBdunDyivrfq34uw39dVvVFHkoizzZPDiYBD8jzXEQfU2mjQ87SDNVZWykkIWZRKKvdAEH2OA9tiEEjUmq5ZqDFCNAaoxWfUnWbVN6PO_H_kAHqJMgld7wU_bwe6_jdWHu_ksnRKf7XkbB9geeR2-q7JiFVdfbq9U9fHm9v7yDVUL9hspr8ec |
CitedBy_id | crossref_primary_10_1161_CIRCRESAHA_113_300219 crossref_primary_10_1007_s12265_012_9443_y crossref_primary_10_1016_j_atherosclerosis_2014_01_027 crossref_primary_10_1186_scrt29 crossref_primary_10_1007_s10554_010_9658_4 crossref_primary_10_1007_s12265_012_9378_3 crossref_primary_10_1007_s00270_020_02625_z crossref_primary_10_1016_j_ahj_2021_06_013 crossref_primary_10_3389_fcvm_2019_00104 crossref_primary_10_1002_micr_20779 crossref_primary_10_1186_1479_5876_11_56 crossref_primary_10_1536_ihj_16_179 crossref_primary_10_1016_j_biomaterials_2016_03_020 crossref_primary_10_1371_journal_pone_0076908 crossref_primary_10_1016_j_ijcard_2010_02_008 crossref_primary_10_1016_j_trsl_2009_06_009 crossref_primary_10_1136_pgmj_2009_192385rep crossref_primary_10_1186_1479_5876_9_183 crossref_primary_10_1186_s13578_023_01099_z crossref_primary_10_1161_CIRCINTERVENTIONS_123_012997 crossref_primary_10_1016_j_addr_2017_10_007 |
Cites_doi | 10.1073/pnas.181177898 10.1002/ccd.20450 10.1097/00029330-200609020-00001 10.1016/j.ijcard.2006.03.028 10.1016/j.cardiores.2004.12.013 10.1093/eurheartj/ehi818 10.1161/01.CIR.0000138191.11580.e3 10.1093/eurheartj/ehi159 10.1016/j.ejcts.2005.01.065 10.1002/ccd.10417 10.1016/j.jtcvs.2007.05.004 10.1002/1522-726X(200011)51:3<358::AID-CCD27>3.0.CO;2-F 10.1002/ccd.20841 10.1016/S0735-1097(03)00397-8 10.3727/000000006783981611 10.1634/stemcells.2005-0212 10.1038/ncpcardio0447 10.1161/hc3501.093817 10.1016/S0735-1097(01)01200-1 |
ContentType | Journal Article |
Copyright | 2008, the Authors Journal compilation ©2008, Wiley Periodicals, Inc. |
Copyright_xml | – notice: 2008, the Authors Journal compilation ©2008, Wiley Periodicals, Inc. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1111/j.1540-8183.2008.00390.x |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1540-8183 |
EndPage | 431 |
ExternalDocumentID | 10_1111_j_1540_8183_2008_00390_x 19012733 JOIC390 ark_67375_WNG_7KMNRFB1_T |
Genre | article Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: K01 AR054114-01A2 – fundername: NIAMS NIH HHS grantid: K01 AR054114 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJEY AAONW AAWTL AAZKR ABCQN ABDBF ABEML ABJNI ABOCM ABPVW ABUWG ACBWZ ACCFJ ACGFS ACMXC ACPRK ACSCC ACXQS ADBBV ADEOM ADIZJ AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFKRA AFPWT AFZJQ AHEFC AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS AMBMR ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BCNDV BDRZF BENPR BHBCM BMXJE BPHCQ BPMNR BROTX BRXPI BSCLL BVXVI BY8 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DC6 DCZOG DPXWK DR2 DU5 EAD EAP EAS EBD EBS EJD EMB EMK EMOBN ENC EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FYUFA FZ0 G-S G.N GODZA GROUPED_DOAJ H.X HF~ HMCUK HVGLF HYE HZI HZ~ IAO IHE IHR INH ITC IX1 J0M K48 LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D PALCI PGMZT PIMPY PQQKQ Q.N Q11 QB0 Q~Q R.K RHX RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c5760-a04ae33bd79132172834959635cae869bcb4f1567e8e59b5d04e2b35f9c3c51b3 |
IEDL.DBID | DR2 |
ISSN | 0896-4327 |
IngestDate | Tue Sep 17 21:25:02 EDT 2024 Fri Oct 25 11:08:19 EDT 2024 Thu Sep 26 18:49:15 EDT 2024 Sat Sep 28 07:53:47 EDT 2024 Sat Aug 24 00:48:23 EDT 2024 Wed Oct 30 09:53:17 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5760-a04ae33bd79132172834959635cae869bcb4f1567e8e59b5d04e2b35f9c3c51b3 |
Notes | istex:DE87E2C9333BB3165795B9DA55C322DE56C43405 ark:/67375/WNG-7KMNRFB1-T ArticleID:JOIC390 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Current address: Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio |
OpenAccessLink | https://europepmc.org/articles/pmc4428662?pdf=render |
PMID | 19012733 |
PQID | 69798946 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4428662 proquest_miscellaneous_69798946 crossref_primary_10_1111_j_1540_8183_2008_00390_x pubmed_primary_19012733 wiley_primary_10_1111_j_1540_8183_2008_00390_x_JOIC390 istex_primary_ark_67375_WNG_7KMNRFB1_T |
PublicationCentury | 2000 |
PublicationDate | October 2008 |
PublicationDateYYYYMMDD | 2008-10-01 |
PublicationDate_xml | – month: 10 year: 2008 text: October 2008 |
PublicationDecade | 2000 |
PublicationPlace | Malden, USA |
PublicationPlace_xml | – name: Malden, USA – name: United States |
PublicationTitle | Journal of interventional cardiology |
PublicationTitleAlternate | J Interv Cardiol |
PublicationYear | 2008 |
Publisher | Blackwell Publishing Inc |
Publisher_xml | – name: Blackwell Publishing Inc |
References | Freyman T, Polin G, Osman H, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006;27:1114-1122. Ott HC, Kroess R, Bonaros N, et al. Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation. Eur J Cardiothorac Surg 2005;27:1017-1021. Hou D, Maclaughlin F, Thiesse M, et al. Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous delivery. Catheter Cardiovasc Interv 2003;58:207-211. Siminiak T, Fiszer D, Jerzykowska O, et al. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: The POZNAN trial. Eur Heart J 2005;26:1188-1195. Thompson CA, Nasseri BA, Makower J, et al. Percutaneous transvenous cellular cardiomyoplasty: A novel nonsurgical approach for myocardial cell transplantation. J Am Col Cardiol 2003;41:1964-1971. Musialek P, Tracz W, Skotnicki AB, et al. Transcoronary stem cell delivery using physiological endothelium-targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over-the-wire balloon coronary occlusions in patients after recent myocardial infarction. Kardiol Pol 2006;64:489-498. Hu CH, Wu GF, Wang XQ, et al. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chin Med J 2006;119:1499-1506. Hou D, Youssef EAS, Brinton TJ, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 2005;112(suppl I):I150-I156. Perin EC, Lopez J. Methods of stem cell delivery in cardiac diseases. Nat Clin Pract Cardiovasc Med 2006;3(suppl I):S110-S113. Leor J, Guetta E, Feinberg MS, et al. Human umbilical cord blood-derived CD133 +cells enhance function and repair of the infarcted myocardium. Stem Cells 2006;24:772-780. Bhakta S, Greco NJ, Finney MR, et al. The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia. J Invasive Cardiol 2006;18:212-218. Baklanov DV, Moodie KM, McCarthy FE, et al. Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs. Catheter Cardiovasc Interv 2006;68:416-423. Ma N, Stamm C, Kaminski A, et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/SCID mice. Cardiovasc Res 2005;66:45-54. Youssef EAS, Zhang P, Rogers PI, et al. Enhancing myocardial plasmid expression by retrograde coronary venous delivery. Catheter Cardiovasc Interv 2005;65:528-534. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol 2001;37:1726-1732. Hou M, Yang KM, Zhang H, et al. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 2007;115:220-228. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-1052. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function, and survival. Proc Natl Acad Sci USA 2001;98:10344-10349. Kim BO, Tian H, Prasongsukarn K, et al. Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005;112(suppl 9):I96-104. Suzuki K, Murtuza B, Fukushima S, et al. Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function. Circulation 2004;110(suppl II):II-225-230. Makela J, Ylitalo K, Lehtonen S, et al. Bone marrow-derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site. J Thorac Cardiovasc Surg 2007;134:565-573. Herity NA, Lo ST, Oei F, et al. Selective regional myocardial infiltration by the percutaneous coronary venous route: A novel technique for local drug delivery. Catheter Cardiovasc Interv 2000;51:358-363. Henning RJ, Burgos JD, Ondrovic L, et al. Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 2006;15:647-658. Marzilli M. Recurrent and resistant angina: Is the metabolic approach an appropriate answer? Coron Artery Dis 2004;15(suppl I):S23-S27. 2007; 115 2004; 110 2007; 134 2006; 64 2006; 119 2006; 24 2006; 68 2005; 112 2006; 27 2004; 15 2006; 15 2000; 51 2003; 58 2006; 18 2005; 65 2006; 3 2001; 37 2005; 26 2005; 27 2003; 41 2001; 104 2005; 66 2001; 98 16510464 - Eur Heart J. 2006 May;27(9):1114-22 15364867 - Circulation. 2004 Sep 14;110(11 Suppl 1):II225-30 16752333 - Kardiol Pol. 2006 May;64(5):489-98; discussion 499 12798567 - J Am Coll Cardiol. 2003 Jun 4;41(11):1964-71 15769447 - Cardiovasc Res. 2005 Apr 1;66(1):45-54 16889848 - Int J Cardiol. 2007 Feb 7;115(2):220-8 11345391 - J Am Coll Cardiol. 2001 May;37(6):1726-32 16195418 - Stem Cells. 2006 Mar;24(3):772-80 11066126 - Catheter Cardiovasc Interv. 2000 Nov;51(3):358-63 11504914 - Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10344-9 15896611 - Eur J Cardiothorac Surg. 2005 Jun;27(6):1017-21 15179125 - Coron Artery Dis. 2004 May;15 Suppl 1:S23-7 11524400 - Circulation. 2001 Aug 28;104(9):1046-52 16159808 - Circulation. 2005 Aug 30;112(9 Suppl):I150-6 12552546 - Catheter Cardiovasc Interv. 2003 Feb;58(2):207-11 16159872 - Circulation. 2005 Aug 30;112(9 Suppl):I96-104 16670448 - J Invasive Cardiol. 2006 May;18(5):212-8 17176616 - Cell Transplant. 2006;15(7):647-58 16501616 - Nat Clin Pract Cardiovasc Med. 2006 Mar;3 Suppl 1:S110-3 16003788 - Catheter Cardiovasc Interv. 2005 Aug;65(4):528-34 16892441 - Catheter Cardiovasc Interv. 2006 Sep;68(3):416-23 17723800 - J Thorac Cardiovasc Surg. 2007 Sep;134(3):565-73 16996002 - Chin Med J (Engl). 2006 Sep 20;119(18):1499-506 15764613 - Eur Heart J. 2005 Jun;26(12):1188-95 Kim BO (e_1_2_6_22_2) 2005; 112 Bhakta S (e_1_2_6_6_2) 2006; 18 e_1_2_6_18_2 e_1_2_6_19_2 Musialek P (e_1_2_6_11_2) 2006; 64 e_1_2_6_13_2 e_1_2_6_10_2 e_1_2_6_16_2 Hou D (e_1_2_6_12_2) 2005; 112 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_20_2 Marzilli M (e_1_2_6_3_2) 2004; 15 e_1_2_6_8_2 e_1_2_6_7_2 e_1_2_6_9_2 e_1_2_6_4_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_21_2 e_1_2_6_26_2 e_1_2_6_25_2 |
References_xml | – volume: 134 start-page: 565 year: 2007 end-page: 573 article-title: Bone marrow‐derived mononuclear cell transplantation improves myocardial recovery by enhancing cellular recruitment and differentiation at the infarction site publication-title: J Thorac Cardiovasc Surg – volume: 15 start-page: S23 issue: suppl I year: 2004 end-page: S27 article-title: Recurrent and resistant angina: Is the metabolic approach an appropriate answer? publication-title: Coron Artery Dis – volume: 58 start-page: 207 year: 2003 end-page: 211 article-title: Widespread regional myocardial transfection by plasmid encoding Del‐1 following retrograde coronary venous delivery publication-title: Catheter Cardiovasc Interv – volume: 27 start-page: 1114 year: 2006 end-page: 1122 article-title: A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction publication-title: Eur Heart J – volume: 112 start-page: I150 issue: suppl I year: 2005 end-page: I156 article-title: Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials publication-title: Circulation – volume: 104 start-page: 1046 year: 2001 end-page: 1052 article-title: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines publication-title: Circulation – volume: 112 start-page: I96 issue: suppl 9 year: 2005 end-page: 104 article-title: Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model publication-title: Circulation – volume: 66 start-page: 45 year: 2005 end-page: 54 article-title: Human cord blood cells induce angiogenesis following myocardial infarction in NOD/SCID mice publication-title: Cardiovasc Res – volume: 26 start-page: 1188 year: 2005 end-page: 1195 article-title: Percutaneous trans‐coronary‐venous transplantation of autologous skeletal myoblasts in the treatment of post‐infarction myocardial contractility impairment: The POZNAN trial publication-title: Eur Heart J – volume: 41 start-page: 1964 year: 2003 end-page: 1971 article-title: Percutaneous transvenous cellular cardiomyoplasty: A novel nonsurgical approach for myocardial cell transplantation publication-title: J Am Col Cardiol – volume: 119 start-page: 1499 year: 2006 end-page: 1506 article-title: Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction publication-title: Chin Med J – volume: 98 start-page: 10344 year: 2001 end-page: 10349 article-title: Mobilized bone marrow cells repair the infarcted heart, improving function, and survival publication-title: Proc Natl Acad Sci USA – volume: 115 start-page: 220 year: 2007 end-page: 228 article-title: Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats publication-title: Int J Cardiol – volume: 24 start-page: 772 year: 2006 end-page: 780 article-title: Human umbilical cord blood‐derived CD133 +cells enhance function and repair of the infarcted myocardium publication-title: Stem Cells – volume: 3 start-page: S110 issue: suppl I year: 2006 end-page: S113 article-title: Methods of stem cell delivery in cardiac diseases publication-title: Nat Clin Pract Cardiovasc Med – volume: 18 start-page: 212 year: 2006 end-page: 218 article-title: The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia publication-title: J Invasive Cardiol – volume: 110 start-page: II‐225 issue: suppl II year: 2004 end-page: 230 article-title: Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: Distribution, dynamics, and influence on cardiac function publication-title: Circulation – volume: 64 start-page: 489 year: 2006 end-page: 498 article-title: Transcoronary stem cell delivery using physiological endothelium‐targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over‐the‐wire balloon coronary occlusions in patients after recent myocardial infarction publication-title: Kardiol Pol – volume: 68 start-page: 416 year: 2006 end-page: 423 article-title: Comparison of transendocardial and retrograde coronary venous intramyocardial catheter delivery systems in healthy and infarcted pigs publication-title: Catheter Cardiovasc Interv – volume: 37 start-page: 1726 year: 2001 end-page: 1732 article-title: Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia publication-title: J Am Coll Cardiol – volume: 15 start-page: 647 year: 2006 end-page: 658 article-title: Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size publication-title: Cell Transplant – volume: 65 start-page: 528 year: 2005 end-page: 534 article-title: Enhancing myocardial plasmid expression by retrograde coronary venous delivery publication-title: Catheter Cardiovasc Interv – volume: 51 start-page: 358 year: 2000 end-page: 363 article-title: Selective regional myocardial infiltration by the percutaneous coronary venous route: A novel technique for local drug delivery publication-title: Catheter Cardiovasc Interv – volume: 27 start-page: 1017 year: 2005 end-page: 1021 article-title: Intramyocardial microdepot injection increases the efficacy of skeletal myoblast transplantation publication-title: Eur J Cardiothorac Surg – ident: e_1_2_6_4_2 doi: 10.1073/pnas.181177898 – ident: e_1_2_6_2_2 – ident: e_1_2_6_26_2 doi: 10.1002/ccd.20450 – ident: e_1_2_6_21_2 doi: 10.1097/00029330-200609020-00001 – volume: 15 start-page: S23 year: 2004 ident: e_1_2_6_3_2 article-title: Recurrent and resistant angina: Is the metabolic approach an appropriate answer? publication-title: Coron Artery Dis contributor: fullname: Marzilli M – ident: e_1_2_6_18_2 doi: 10.1016/j.ijcard.2006.03.028 – ident: e_1_2_6_23_2 doi: 10.1016/j.cardiores.2004.12.013 – ident: e_1_2_6_7_2 doi: 10.1093/eurheartj/ehi818 – ident: e_1_2_6_9_2 doi: 10.1161/01.CIR.0000138191.11580.e3 – ident: e_1_2_6_13_2 doi: 10.1093/eurheartj/ehi159 – volume: 112 start-page: I96 issue: 9 year: 2005 ident: e_1_2_6_22_2 article-title: Cell transplantation improves ventricular function after a myocardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model publication-title: Circulation contributor: fullname: Kim BO – ident: e_1_2_6_8_2 doi: 10.1016/j.ejcts.2005.01.065 – ident: e_1_2_6_25_2 doi: 10.1002/ccd.10417 – ident: e_1_2_6_19_2 doi: 10.1016/j.jtcvs.2007.05.004 – ident: e_1_2_6_24_2 doi: 10.1002/1522-726X(200011)51:3<358::AID-CCD27>3.0.CO;2-F – ident: e_1_2_6_14_2 doi: 10.1002/ccd.20841 – ident: e_1_2_6_10_2 doi: 10.1016/S0735-1097(03)00397-8 – ident: e_1_2_6_20_2 doi: 10.3727/000000006783981611 – ident: e_1_2_6_5_2 doi: 10.1634/stemcells.2005-0212 – ident: e_1_2_6_15_2 doi: 10.1038/ncpcardio0447 – ident: e_1_2_6_16_2 doi: 10.1161/hc3501.093817 – ident: e_1_2_6_17_2 doi: 10.1016/S0735-1097(01)01200-1 – volume: 18 start-page: 212 year: 2006 ident: e_1_2_6_6_2 article-title: The safety of autologous intracoronary stem cell injections in a porcine model of chronic myocardial ischemia publication-title: J Invasive Cardiol contributor: fullname: Bhakta S – volume: 64 start-page: 489 year: 2006 ident: e_1_2_6_11_2 article-title: Transcoronary stem cell delivery using physiological endothelium‐targeting perfusion technique: The rationale and a pilot study involving a comparison with conventional over‐the‐wire balloon coronary occlusions in patients after recent myocardial infarction publication-title: Kardiol Pol contributor: fullname: Musialek P – volume: 112 start-page: I150 year: 2005 ident: e_1_2_6_12_2 article-title: Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials publication-title: Circulation contributor: fullname: Hou D |
SSID | ssj0020552 |
Score | 2.0007691 |
Snippet | Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed... Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to determine... Background: Clinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed... BACKGROUNDClinical trials using intracoronary (IC) delivery of cells have addressed efficacy but the optimal delivery technique is unknown. Our study aimed to... |
SourceID | pubmedcentral proquest crossref pubmed wiley istex |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 424 |
SubjectTerms | Analysis of Variance Angioplasty, Balloon, Coronary - methods Animals Bone Marrow Transplantation - methods Contrast Media Coronary Angiography - methods Disease Models, Animal Fluoroscopy Myocardial Infarction - therapy Myocardial Reperfusion - methods Regeneration Stem Cell Transplantation - methods Sus scrofa |
Title | Transvenous Intramyocardial Cellular Delivery Increases Retention in Comparison to Intracoronary Delivery in a Porcine Model of Acute Myocardial Infarction |
URI | https://api.istex.fr/ark:/67375/WNG-7KMNRFB1-T/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1540-8183.2008.00390.x https://www.ncbi.nlm.nih.gov/pubmed/19012733 https://search.proquest.com/docview/69798946 https://pubmed.ncbi.nlm.nih.gov/PMC4428662 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQIiEuvB_h6QPilqqxkzg-Ll3KdlELqnbF3izbcbSrlhS1Kdrlr_BnmXEe3cAeEOKWKH5l8k1mJp58Q8gb7iIrZZKHqdYsjE0EOqd1HrJYcO0SyYynY5jO0sOT-Og0OW3yn_BfmJofovvghprh39eo4Nps-kqOm_pgcHibEgnx-wD9yYgLzO46mHdMUmyY-OI7w0ymYcyZ6Cf1XDtQz1LdRKFfXOeG_plNedXL9WZqfJcs2huss1MWg21lBvbHb9yP_0cC98idxpul-zX87pMbrnxAbk2b_fqH5Kc3hd89Dyyd4MK_XoLxRFAu6cgtl5gESw9gHaBRl9ACfdiN29A5-vKIGXpe0lFXK5FWq3oYi8QLsPJdX2in6efVGiemWOFtSVcF3bfbCk53k07KAlQbR35ETsbvj0eHYVMOIrQQFA1DPYy149zkQkIIjXW1OER38AJJrHZZKo01cQHhqHAZgMwk-TB2zPCkkJbbJDL8MdkrV6V7SqgxENVmholI2jgrhMm5YdrkDryfwgoekKh99OpbzfqhrkRLIHWFUm9qeKLU1UVA3nqMdB30eoFZcyJRX2YflPg4nc3H7yJ1HJDXLYgU6DJu0OjSwXNQqRTIh58G5EkNqd3kElMEOCxM9MDWNUCW8P6V8vzMs4XHEGCmKQtI6rH01_ejjj5NRnD07F87Pie3WUseHL0ge9V6616CB1eZV143fwG-AztR |
link.rule.ids | 230,315,783,787,888,1378,27938,27939,46308,46732 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hVgIu5V3Mq3tA3BzZXtvrPZaUkLRNQFEqelvtrteiquug1EEtf4U_y4xfqaEHhLjZ8r48ns8z4x1_Q8hbZn0jRJS6sVKBG2ofMKdU6gYhZ8pGItAVHcN0Fo9PwsPT6LQpB4T_wtT8EN0HN0RG9b5GgOMH6T7KcVcfLA5rcyIhgB-AQ7kN6GdYzuBg3nFJBV5Uld_xEhG7IQt4P63n1pF6tmobxX51myP6Zz7lTT-3MlSjByRvb7HOTzkfrEs9MD9-Y3_8TzJ4SHYah5bu1xr4iNyxxWNyd9ps2T8hPytr-L2igqUTXPnFNdhP1MucDm2eYx4sPYCFAKiuoQW6sZf2ks7RnUe1oWcFHXblEmm5rIcxyL0AS9_0hXaKfl6ucGKKRd5yuszovlmXcLqZdFJkgG4c-Sk5GX1YDMduUxHCNRAXea7yQmUZ0ykXEEVjaS0GAR68QyKjbBILbXSYQUTKbQJ6pqPUC22gWZQJw0zka_aMbBXLwj4nVGsIbBMdcF-YMMm4TpkOlE4tOECZ4cwhfvvs5bea-EPeCJhA6hKl3pTxRKnLK4e8q5Sk66BW55g4xyP5ZfZR8qPpbD5678uFQ_ZaLZIAZ9yjUYWF5yBjwZESP3bIbq1Tm8kFZgkwWBjvaVvXAInC-1eKs68VYXgIMWYcBw6JK2X66_uRh58mQzh68a8d98i98WJ6LI8ns6OX5H7Qcgn7r8hWuVrb1-DQlfpNBdRfU8c_aw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb5tAEF5ViRT10veD9JE9VL1hAQu7cEztunFSu5GVqLmtdpdFjeziyMFR0r_SP9uZxeDQ5lBVvYHYF8M3zAw7fEPIO2ZDk2VJ7nOlIj_WIeicUrkfxYIpm2SRdnQM4wk_OI0Pz5Kzdf4T_gtT80O0H9xQM9z7GhX8Ii-6So6b-mBwWJMSCfF7D_zJ7ZizANO7BtOWSioKEld9J0gz7scsEt2snjtH6piqbZT69V1-6J_plLfdXGenhg_JrLnDOj1l1ltVumd-_Eb--H9E8Ig8WLuzdL_G32Nyz5ZPyM54vWH_lPx0tvDKEcHSES78-w1YT0TlnPbtfI5ZsHQA6wCVuoEW6MRe2ks6RWceQUPPS9pviyXSalEPY5B5AVa-6QvtFD1eLHFiiiXe5nRR0H2zquB0M-moLEC3ceRn5HT48aR_4K_rQfgGoqLAV0GsLGM6FxnE0FhYi0F4B2-QxCib8kwbHRcQjwqbAsp0kgexjTRLiswwk4SaPSdb5aK0LwnVGsLaVEcizEycFkLnTEdK5xbcn8II5pGwefTyoqb9kLfCJZC6RKmvi3ii1OW1R947jLQd1HKGaXMikV8nn6Q4Gk-mww-hPPHIXgMiCcqMOzSqtPAcJM8EEuJzj7yoIbWZPMMcAQYLEx2wtQ2QJrx7pTz_5ujCY4gwOY88wh2W_vp-5OGXUR-Odv-14x7ZOR4M5efR5OgVuR81RMLha7JVLVf2DXhzlX7r1PQXXps-Gg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transvenous+intramyocardial+cellular+delivery+increases+retention+in+comparison+to+intracoronary+delivery+in+a+porcine+model+of+acute+myocardial+infarction&rft.jtitle=Journal+of+interventional+cardiology&rft.au=George%2C+Jon+C&rft.au=Goldberg%2C+Jonathan&rft.au=Joseph%2C+Matthew&rft.au=Abdulhameed%2C+Nasreen&rft.date=2008-10-01&rft.eissn=1540-8183&rft.volume=21&rft.issue=5&rft.spage=424&rft.epage=431&rft_id=info:doi/10.1111%2Fj.1540-8183.2008.00390.x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0896-4327&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0896-4327&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0896-4327&client=summon |